Hydrochloric Acid → 1-Methyl-2-quinoxalin-2-yl-1,2,4,5,6,7-hexahydro-pyrazolo[4,3-c]pyridin-3-one hydrochloride

HRID 394512ノート

反応式

HRID 394512 の反応式
C(OC([N:8]1[CH2:13][CH2:12][C:11]2[N:14]([CH3:28])[N:15]([C:18]3[CH:27]=[N:26][C:25]4[C:20](=[CH:21][CH:22]=[CH:23][CH:24]=4)[N:19]=3)[C:16](=[O:17])[C:10]=2[CH2:9]1)=O)(C)(C)C.[ClH:29]>CO>[ClH:29].[CH3:28][N:14]1[C:11]2[CH2:12][CH2:13][NH:8][CH2:9][C:10]=2[C:16](=[O:17])[N:15]1[C:18]1[CH:27]=[N:26][C:25]2[C:20](=[CH:21][CH:22]=[CH:23][CH:24]=2)[N:19]=1

参加物

4

反応条件

温度
60 °C

実験手順

To a solution of 1-methyl-3-oxo-2-quinoxalin-2-yl-1,2,3,4,6,7-hexahydro-pyrazolo[4,3-c]pyridine-5-carboxylic acid tert-butyl ester (prepared according to the method of Example 75, Step B, 279 mg, 0.73 mmol) in methanol (6 mL) was added hydrogen chloride (5.85 M in methanol, 1.25 mL, 7.3 mmol). This mixture was heated at 60° C. for 30 min, cooled to room temperature, and concentrated to give 249 mg (>100%) of the title compound of Example 75, Step C as a dark red solid. 1H NMR (CD3OD, 250 MHz) δ 9.45 (s, 1H), 8.13 (dd, 1H), 8.05 (m, 1H), 7.91-7.83 (c, 2H), 4.05 (s, 2H), 3.64 (t, 2H), 3.56 (s, 3H), 3.12 (t, 2H); MS (APCI) 282 (MH+).

後処理

  1. temperaturecooled to room temperature
  2. concentrationconcentrated

出典と根拠

ORDレコード
ord-f1b64dd9cfed45158d982320b7a9d4ea
出典データセット
uspto-grants-2003_08
特許番号
US06602875B2

反応ノート

読み込み中…